Login / Signup

Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer.

Vicky SmithDebayan MukherjeeAnna Maria TsakiroglouAlexander R BakerHitesh MistryAnanya ChoudhuryPeter J HoskinTimothy M IllidgeCatharine M L West
Published in: Cancers (2022)
MIBC with low CD8+ T cell counts may benefit from hypoxia-modifying treatment.
Keyphrases
  • muscle invasive bladder cancer
  • endothelial cells
  • peripheral blood
  • stem cells
  • combination therapy
  • bone marrow
  • replacement therapy
  • smoking cessation